Targeting Thrombophilia in Sickle Cell Disease with Isoquercetin: Results of a Fixed Dose, Single Center, Phase II Randomized Clinical Trial
- Authors:
- Maria A. Lizarralde-Iragorri
- Bindu Parachalil Gopalan
- Brenda Merriweather
- Jennifer Brooks
- Mai Hill
- Anna Conrey
- Ruth Pierre Charles
- Eveline Gwaabe
- Neal Jeffries
- Arun S. Shet
- Reference:
- Blood
- 2022
- 140, Supplement 1
- 8270–8271
- DOI:
- 10.1182/blood-2022-166518